vimarsana.com
Home
Live Updates
Tetra Pharm Technologies advances CB1 antagonist, TPT0701, f
Tetra Pharm Technologies advances CB1 antagonist, TPT0701, f
Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing
/PRNewswire/ -- Following the successful filing of Intellectual Property (IP) for their applied platform technology targeting the endocannabinoid system (ECS),...
Related Keywords
Copenhagen ,
Køavn ,
Denmark ,
Danish ,
Martin Caspersen ,
Pharm Technologie ,
Martin Rose ,
Morten Alles ,
,
Tetra Pharm Technologies ,
Intellectual Property ,
Chief Scientific Officer ,
Tetra Pharm Technologie ,
Chief Executive Officer ,
Tetra Pharm ,